Member Info for Saxondale

Very Happy with the way that RNS reads .
All confident , building up commercialisation .
New board member .
All gearing up .
Plenty of cash .
Exactly what I expected to hear .

We should be getting Bex updates through the autumn which could be all sorts :
News on soluble clever1 and dosing /frequency findings etc .
Also news regarding biomarkers for selecting patients -
News relating to specific cohorts ( breast cancer possibly )

News on funding - could drop anytime if a partnership deal is agreed .

G20 meeting - If they make it through to the final selection - that would be incredible news .

Hibscus - update after the P2 - probably late Q4 at the earliest.

But often we get some news from unexpected corners at Faron .

I'm still intrigued with the EIC/G20 connection , if there is one , and with the data from the Matins trial being evaluated - Faron definitely have something valuable , but as normal we just have to sit patiently and watch the SP do its thing until news lands .

RNS
Overdue
With
Kippers
Attached

Freudian slip there I fear .
I always have a running joke with my missus whenever she bought a new dress ( not for along time ) , I use to say , Oh thats lovely , what did you do with the other curtain lol .

Nice one Itsall - good to see them replying . And the messages have just appeared now .
That Renschler arbitration could amount to quite a payment if it goes Farons way . And it was no win no fee , so can only be a positive outcome with no risk .

Anyone else curious as to why Faron got selected to present at the G20 Innovation Summit ?
Out of so many possible companies ?

Does it help to already have the attention of the EIC ( European Innovation Council ) who have not only helped by way of grants , but also in directly investing through the last placement ( Incidentally Faron were the first company that the EIC directly invested in ) .
As the EIC is part of the European Commission , they are part of the EU G20 .

So I guess the Commission get asked to put forward their best investment opportunities .

And to consider all the companies out there that are looking for funding , Faron get chosen .

This isn't any old investor conference . We are talking delegates from the countries than run 80% of the worlds GDP . The banks they operate with are the central banks of each country . They'll probably spend more than $15 million just on schmoozing in Sorrento .

Faron would have known about this surely , well before recent interviews . Hence the slightly dismissive answers when questioned about funding .

Do you get the feeling they are being lined up infront of just the right sort of people . I may be getting a bit ahead of myself , but it does seem a big step up from the usual sort of conference .

Noted the comment form the CEO of the UK's Bioindustry Association :
Bates said he would be “unsurprised” to see at least one antiviral drug ready to be rolled out in the coming weeks, potentially under an “emergency use authorisation”, through which products yet to win full regulatory approval can be made available during a public health crisis.

Fits the scenario of moving to P3 in Activ2 .

At least one ?

Imagine having to do a report on the shortage of dentists and your name's Phil McCavity .

Only just catching up here on these whispers coming from various sources . Very intriguing , and nice that they seem to be taken somewhat seriously by people whose opinions i read . I'm happy enough here with what we've found up to date . Almost forgot about that extra pile of gold they found last time under the existing pile .
SP hasn't budged a smidge recently , so I did think the first little whaft of a rumour may have been a bit of a wheeze to scare shorters and play them at their own game .
I've got enough excitement kicking off at EUA now , so to have GGP come out with some gargantuan find of unexpected treasure in the next few weeks means I may have to buy some elasticated pants incase of an RNS induced accident lol
Either way , I love a good rumour . Whoever's on the case - keeping digging ( no pun intended)

Who knows Tim ? Baffling . I liked the idea someone came up with that politicians and people in medical bodies should have to wear suits similar to race car drivers , covered in the names that sponsor them , so its obvious where their allegiances lie .
WHO gave Interferon the elbow , but it was all done on behalf of Merck with their subcutaneous IFN ( I/V never got a look in there , although with no steroid free domain , it probably wasn't the best scenario) . I/V Interferon has had to go down its own P3 trial ( funded by the US Department of Defense for $6million) , although again , its very low key . No media hype or hopes expressed by anyone outside the actual company .
We are still in full on ' vaccine first ' media mode , and I think after Trump 'bleach gate' etc , media may be wary of reporting hopes on drugs still under trials , some of which get overhyped for the benefit of unscrupulous carpet baggers. Plus the main sites just report whats given to them . Not much investigative journalism anymore , just print what you're given and follow the agenda .
I have been heartened by things like the recent youtube vid by the Medical Research Council regarding Synairgen , and they even took the trouble to answer my comment .

Plenty of IFN data being published in respected journals , but until we get results , we won't see any real limelight.

I have a feeling that plenty is going on behind the scene in preparation though .

So looking forward to the next few weeks now .
Wow its been a long ride . Back in suspension I thought it would be so simple - obviously I had no idea as to the working of the company , or their master plan back then , and how much there was to sort out .
Not the easiest share to hold if you don't really understand the mechanics , as its easy to be misled or baffled .
The last couple of RNS's have shown us that we really are getting close to the end game now .
The SP games have gone on so long now I'm actually immune to the emotional side of seeing my pot rise and fall by £1000s every hour , if anything it just confirms my faith in whats going to happen at the end of all this .

So thanks to the crew on here that have kept the faith , enlightened us with facts , and set the record straight when needed.

I hope that EUA will change peoples lives , and we can all look back on this period as a life lesson , to hold firm with your convictions , and not to be swayed . He who dares Rodney . Our lives will be richer for the experience .

It might not happen on Monday , but once that JORC lands , its gonna be whole lot harder to worry people out of their shares .

Mostly vaccination talk , but he's literally just mentioned that an inhaled therapeutic is being studied , and sees something like that as the holy grail . That is his mind would be the biggest game changer . I see that as a big plus - as if we were having issues on Activ 2, surely he wouldn't have mentioned it . Happy days .

On YouTube in a few minutes -Dr Wohl
https://www.youtube.com/watch?v=QA76ENkPJ9M

Good find Dan , the links between Helsinki and the DofD just keep growing . I'm sure I saw another one similar to that a few months ago . The US is basically a huge global company in disguise , so using the DofD is a clever way of getting your feet under the table .
In relation to Traumakine , in the webinar , Markku said the DofD know what they're doing .
It was almost an off the cuff remark , but I took it as being , they've been involved with T for a long time , and wouldn't still be here pumping money in, if there wasn't going to be some payoff .
Plus we don't know what else has been going on in the background as far as lab research . Hollmen lab working , Cancer IO working , DofD working .
Now this G20 Investor forum . 100 top prospects chosen to be wafted under the noses of the G20 investment bodies . Only 14 Healthcare companies chosen . This seems like a fairly privileged invitation . Not exactly akin to a small booth at the NEC .

I hope they continue this ramping up of exposure .

The Americans seem to be one step ahead of us as far a prepping for Armageddon . They got the gold , then piles of silver for buying their goods , then the pump action shotgun for getting a better price . Not sure if my 22 air rifle is gonna cut the mustard down at the greengrocer . Images of Hot Fuzz come to mind lol

At least you had some profit . I'm the worst trader , too greedy to sell and I never see a spike as a spike until its too late .
I keep a separate account now for a little side trading , but I still manage to bodge most of them up .
Never sell when I'm up a bit , but do sell when I'm down cos I've spotted another rainbow . I'm my own worst enemy .
Still , takes a while to learn from your mistakes , and I'm still learning .

I'm getting quite used to SP not reflecting where things should be , but that's the nature of the stock market .
Unless something is black and white clear as day RNS'd , there is room for drifting , playing about , accumulating , ( shorting - although I think thankfully we are free of that here ), and general squeezing .

I really wish with my long term shares , I could just leave looking at them ( like my pension). But I guess there are some shares that are actually become a sort of hobby , as we like the story too ( For me FARN , SNG , EUA and GGP ) , and enjoy looking for clues and tidbits of info .

Sometimes however , best thing to do is just wait for the RNS's and avoid panicky feelings about falling SPs .

Case in point where I learnt my lesson - years ago when I first bought £500 of FARN at £1 , I also bought £500 of REDX at 14p .
Sold REDX at 7p a year later as I was peeved that it seemed to be going nowhere , despite some promising research .
Made the mistake of checking it again today - oohh £1.08 . Infact it went to 50p about 2 weeks after I sold .

Its almost a nailed on phenomenon , that as a share gets closer to the money RNS's , so the SP tends to look weaker and weaker .

3 years ago I'd be scratching my head . Now I'm almost expecting it , and actually see it as a necessary process , when some bigger hands decide they want some of the pie , they have no problem bullying a few weaker hands out of the way .

It's hold on for the endgame here for me . Plenty of risk has been removed in what they've proved up so far , and the rewards will be worth the shenanigans .

Reminds me of George Best - I spent a lot of money on booze, birds and fast cars. The rest I just squandered.

Breast cancer -$29 billion dollar market - and expected to grow to $34 billion in the next 5 years .
Takes a minute to compute what this could mean for our little company .

Thanks mathiaso . Always worth re-reading these presentations , as new stuff gets slipped in , and compared to the ones last year - the outlook is now very bullish - we never used to get slides devoted to market share , and talking of US presence and building several partnerships with world leading pharma companies.Now we do .
Slides 22/23 and Slide 37 worth a full read .